● Recruiting

A Study to Evaluate 608 in Patients With Non- Radiographic Axial Spondyloarthritis (Nr-axSpA)

Condition: Axial Spondyloarthritis · Sponsor: Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.

PhasePhase 2

Planned participants180

Who can joinAll sexes, 18 Years to no upper limit

Healthy volunteersNo

About this study

This study will evaluate the effect and safety of 608 in patients with nr-axSpA.

This description comes directly from the study's public registry record.

Talk to the study team

Qinghong Zhou, BS · 18911301578 · zhouqinghong@3sbio.com

Always discuss trial participation with your own doctor first.

Locations (6)

Site 01	Beijing, Beijing Municipality, China	Recruiting
Site 03	Beijing, Beijing Municipality, China	Recruiting
Site 05	Chongqing, Chongqing Municipality, China	Recruiting
Site 02	Zhengzhou, Henan, China	Recruiting
Site 04	Nanjing, Jiangsu, China	Recruiting
Site 06	Shenzhen, Shenzhen, China	Not Yet Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06222671